Federation Des Caisses Desjardins Du Quebec Novavax Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$19 Billion
Q1 2025

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Novavax Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 955 shares of NVAX stock, worth $6,608. This represents 0.0% of its overall portfolio holdings.

Number of Shares

955

Previous 930 2.69%

Holding current value

$6,608

Previous $7,000 14.29%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$6.41 - $10.82 $160 - $270	25 Added 2.69%	955 $6,000
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $3,496 - $5,598	930 New	930 $4.45 Million
Q4 2023 Aug 14, 2024	SELL	$4.8 - $7.67 $6,000 - $9,587	-1,250 Reduced 57.34%	930 $4.46 Million
Q3 2023 Aug 14, 2024	SELL	$6.81 - $9.74 $13,735 - $19,645	-2,017 Reduced 48.06%	2,180 $15.8 Million
Q1 2023 Aug 14, 2024	BUY	$5.76 - $12.48 $576 - $1,248	100 Added 2.44%	4,197 $29.1 Million
Q4 2022 Aug 14, 2024	BUY	$8.86 - $25.04 $886 - $2,504	100 Added 2.5%	4,097 $42.1 Million
Q3 2022 Aug 14, 2024	SELL	$18.2 - $76.12 $582 - $2,435	-32 Reduced 0.79%	3,997 $72.7 Million
Q2 2022 Aug 14, 2024	BUY	$36.28 - $75.29 $21,223 - $44,044	585 Added 16.99%	4,029 $207 Million
Q1 2022 Aug 14, 2024	BUY	$69.73 - $142.9 $175,301 - $359,250	2,514 Added 270.32%	3,444 $254 Million
Q4 2021 Aug 30, 2024	SELL	$134.56 - $217.97 $275,040 - $445,530	-2,044 Reduced 44.94%	2,504 $358 Million
Q3 2021 Aug 30, 2024	BUY	$177.8 - $270.58 $514,731 - $783,329	2,895 Added 175.14%	4,548 $943 Million
Q2 2021 Aug 30, 2024	BUY	$121.0 - $257.67 $87,483 - $186,295	723 Added 77.74%	1,653 $351 Million
Q1 2021 Aug 30, 2024	SELL	$112.98 - $319.93 $245,618 - $695,527	-2,174 Reduced 72.9%	808 $146 Million
Q4 2020 Aug 30, 2024	BUY	$78.74 - $139.5 $154,724 - $274,117	1,965 Added 193.22%	2,982 $333 Million
Q3 2020 Aug 30, 2024	SELL	$79.44 - $178.51 $49,093 - $110,319	-618 Reduced 37.8%	1,017 $110 Million
Q2 2020 Aug 30, 2024	SELL	$13.86 - $83.61 $7,137 - $43,059	-515 Reduced 23.95%	1,635 $136 Million
Q1 2020 Aug 30, 2024	BUY	$3.93 - $16.0 $8,351 - $34,000	2,125 Added 8500.0%	2,150 $29.2 Million
Q2 2019 Aug 30, 2024	SELL	$4.93 - $12.2 $4,461 - $11,041	-905 Reduced 97.31%	25 $147,000

Others Institutions Holding NVAX

# of Institutions

299

Shares Held

90M

Call Options Held

5.76M

Put Options Held

6.65M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $541M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Novavax Inc Transaction History